Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Mark A. Talamini, MD, Named Editor-in-Chief of Surgical Endoscopy

 

July 15, 2009  |  

Mark A. Talamini, MD, professor and M. J. Orloff Family chair of the department of surgery at UC San Diego Medical Center is the new Editor-in-Chief of Surgical Endoscopy, the official journal of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and European Association for Endoscopic Surgery.

Talamini, MD

Talamini is a pioneer in minimally invasive surgery

A top-ranked journal, Surgical Endoscopy is a leading source of information on the practice, theory, and research of interventional endoscopy, ultrasound, and other techniques in the fields of gastroenterology, obstetrics, gynecology, and urology. It also covers work in gastroenterologic, thoracic, traumatic, orthopedic, and pediatric surgery.

“Dr. Talamini is a groundbreaking surgeon who is transforming the world of scarless surgical techniques,” said David Brenner, MD, UC San Diego Vice Chancellor of Health Sciences and Dean of the School of Medicine. “Always at the nexus of what is new, he will bring his drive for innovation and clinical excellence to this new editorial role.”

In 2008, his surgical team gained worldwide attention for pioneering natural orifice translumenal endoscopic surgery (NOTES), the practice of removing diseased organs through natural body openings. Part of the UC San Diego Center for the Future of Surgery, the team was the first in the United States to remove an appendix through the mouth and through the vagina.

A highly respected surgeon, researcher, and teacher, Talamini is recognized as one of the leading authorities on laparoscopic and robotic-assisted surgery in the United States. In his clinics and surgeries at UC San Diego Medical Center and Moores UCSD Cancer Center, he specializes in gastrointestinal surgery, with a particular emphasis on the treatment of inflammatory bowel disease. Talamini is the author of Advanced Therapy in Minimally Invasive Surgery, an in-depth exploration of new and emerging surgical practices.

The editorial role at Surgical Endoscopy, published by Springer, will be shared with Sir Alfred Cuschieri of the University of Dundee. Talamini will be primarily responsible for submissions from North and South America and Asia.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu


Related Specialties

Department of Surgery


Media Contact

Related News

5/1/2015
Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) an ...
5/1/2015
In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in ce ...
4/30/2015
Researchers at University of California, San Diego School of Medicine report a previously unappreciated phenomenon in which the location of injury to a neuron’s communication wire in the spinal cord — ...
4/30/2015
Urinary tract infections (UTIs) are common, and widespread antibiotic resistance has led to urgent calls for new ways to combat them. Researchers at University of California, San Diego School of Medic ...
4/29/2015
Offering a potential early intervention for Alzheimer’s disease (AD), researchers at University of California, San Diego School of Medicine and Cenna Biosciences, Inc. have identified compounds that b ...
4/29/2015
A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity amon ...
4/29/2015
Researchers at University of California San Diego School of Medicine report pancreatic cancer rates are highest in countries with the least amount of sunlight. Low sunlight levels were due to a combin ...
4/29/2015
Researchers at the University of California, San Diego School of Medicine report that blocking or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it acti ...


Share This Article



Follow Us